Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep vs moderate neuromuscular blockade in laparoscopic donor nephrectomy
2016-002924-99Phase 4Completed
- Sponsor
- Radboudumc
- Start
- Aug 2016
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of Sugammadex in None (2 arms), sponsored by Radboudumc. Primary endpoint: Quality of Recovery score (QoR-40 questionnaire) - primary. Started Aug 2016; status: completed.
02
Drugs
Sugammadex
Beyond the preview
Go deeper on 2016-002924-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002924-99.